Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.


Published on .

After potential suitors SmithKline Beecham and Glaxo Wellcome went by the wayside, American Home Products Corp. tied the knot with Monsanto Co. in a $35 billion stock swap merger. The companies -- a new name is not yet decided -- are estimated to have 1998 sales of $23 billion.

The former AHP will get strength from Monsanto's G.D. Searle pharmaceutical unit, with a potential arthritis drug that could have other important uses.

Most Popular
In this article: